melanoma and other skin tumoursIpilimumab (IPI) vs placebo (PBO) after complete resection of stage III melanoma: final overall survival results from the EORTC 18071 randomized, double-blind, phase 3 trial
暂无分享,去创建一个
P. Ascierto | R. Dummer | J. Wolchok | A. Eggermont | A. Testori | M. Smylie | H. Schmidt | J. Grob | V. Chiarion-Sileni | C. Lebbé | O. Hamid | J. Weber | S. Suciu | V. Ferraresi | J. Richards | C. Taitt | C. Robert | G. D. Schaetzen | V. D. Pril